Log In
CQMS
Make a Donation
Log In
Donate
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Mission and Values
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2026 Annual Scientific Meeting
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • TROG Km’s for Cancer Research Challenge
    • Donate or fundraise for TROG
    • Ways to Donate
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Mission and Values
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2026 Annual Scientific Meeting
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • TROG Km’s for Cancer Research Challenge
    • Donate or fundraise for TROG
    • Ways to Donate
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Strategic Plan 2020-2023
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Upcoming Trials
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Ways to Donate
    • Donate or fundraise for TROG
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Strategic Plan 2020-2023
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Upcoming Trials
    • Past Trials
    • Publications
  • Participants & Carers
    • Participant Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Ways to Donate
    • Donate or fundraise for TROG
    • TROG Ambassadors
  • Contact Us
TROG ASM2026 - Submit your abstract before 3 October 2025
TROG 2026 ASM: Early Bird Registration now open
Join our Km's for Cancer Research challenge this October
Click Here

TROG 03.06/VCOG PR 01-03 – TOAD

    1. Home
    2. Trial
    3. TROG 03.06/VCOG PR 01-03 – TOAD
  • By w.paterson
  • 14 August, 2021
  • 0 Comments
Completed
Bladder, Kidney & Prostate

A collaborative randomised phase III trial: The timing of intervention with androgen deprivation in prostate cancer patients with a rising PSA.

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)
Prev Post

TROG 03.07 – Non Small Cell Lung Cancer

Next Post

TROG 03.02

Related Post

16 September, 2025

Expanded access to radiation therapy Talking Book to support Aboriginal and Torres Strait Islander consumers

LATEST NEWS: 16 September 2025 A ‘Talking Book’ which

26 August, 2025

Welcome to new TROG committee members and thank you to long-serving members

LATEST NEWS: 26 August 2025 The TROG Scientific Committee

Recent Posts

  • Expanded access to radiation therapy Talking Book to support Aboriginal and Torres Strait Islander consumers
  • Welcome to new TROG committee members and thank you to long-serving members
  • TROG 15.03/ANZUP 16001 FASTRACK II: economic analysis shows new technique is cheaper and more effective in the Australian setting
  • World Lung Cancer Day: Focus on the TROG Lung Working Party
  • TROG 21.07 SOCRATES HCC Trial Expands Outreach

Categories

  • Events 11
  • General 29
  • Journal 1
  • Participant Stories 12
  • Prostate Cancer 2
  • RAVES Trial 1
  • Trials 22

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Facebook-f X-twitter Youtube Instagram Bluesky Streamline Icon: https://streamlinehq.com Bluesky

Quick Links

  • About Us
  • Our Research
  • Participants & Carers
  • Health & Research Professionals
  • News & Resources
  • Support Us
  • Contact Us

Legalities

  • Privacy Policy
  • Complaints & Feedback
  • Copyright Statement
  • Terms & Conditions
  • Cookie Warning
  • TROG Constitution

Latest News

Keep up to date with TROG news, subscribe to our community newsletter.

Subscribe

ABN:  45 132 672 292

TROG Cancer Research © 2025. All rights reserved

Website developed by the Marketing GP